Revolution Medicines(RVMD) - 2025 Q1 - Earnings Call Transcript

Revolution Medicines (RVMD) Q1 2025 Earnings Call May 07, 2025 04:30 PM ET Company Participants Ryan Asay - SVP & Corporate AffairsMark Goldsmith - CEO, President & ChairmanSteve Kelsey - President of Research & DevelopmentWei Lin - Chief Medical OfficerJack Anders - Chief Financial OfficerNone - ExecutiveJonathan Chang - Senior Managing DirectorClara Dong - Vice President - Biotechnology Equity Research Conference Call Participants Michael Schmidt - Senior Managing Director & Equity Research Analyst - Biot ...